Investing.com - Needham已将Carvana Co. (NYSE: CVNA )的目标价从340.00美元上调至500.00美元，同时在该公司第二季度业绩公布后维持"买入"评级。根据 InvestingPro 数据，该股票在过去一年中实现了令人印象深刻的150%回报率，尽管目前其市盈率相对较高，为107。

Investing.com - Needham将AtriCure (NASDAQ:ATRC)的目标价从44.00美元上调至45.00美元，同时维持买入评级，这是在该公司公布2025年第二季度财务业绩后作出的决定。根据InvestingPro数据，该公司保持强劲的财务健康状况，流动比率为4.11，表明其流动性充足。 AtriCure报告的第二季度收入、EBITDA和每股收益均超过了市场预期，促使公司 ...

Laura Martin, Needham & Co. Senior internet analyst, joins CNBC's 'Power Lunch' to discuss outlooks on the AI competitive landscape, expectations for OpenAI's acquisition of iPhone designer Jony ...

NEEDHAM & CO LLC used to own units in Common Stock but no longer holds any shares there.acquired a total of 9,155,379 shares in SOUTHWALL TECHNOLOGIES INC /DE/ at a cost of $91,553.79, NEEDHAM ...

Blockchain Capital, which invests exclusively in bitcoin and blockchain startups, has hired a Needham & Co. analyst as a managing director. Spencer Bogart, who covered bitcoin and blockchain ...

No members of congress have invested in Needham & Co in 2018. Feel free to distribute or cite this material, but please credit OpenSecrets. For permission to reprint for commercial uses, such as ...

Sept 24 (Reuters) - Needham & Co downgraded Natus Medical Inc , a maker of neurodiagnostic and newborn care products, to "hold" from "buy," saying the hospital capital spending was slowing.